Périodique
Co-morbidity of smoking in patients with psychiatric and substance use disorders
(Comorbité du tabagisme chez des patients présentant des troubles psychiatrique et un usage de drogues.)
Auteur(s) :
KALMAN, D. ;
MORISSETTE, S. B. ;
GEORGE, T. P.
Année
2005
Page(s) :
106-123
Langue(s) :
Anglais
Refs biblio. :
165
Domaine :
Tabac / Tobacco / e-cigarette
Discipline :
PSY (Psychopathologie / Psychopathology)
Thésaurus mots-clés
COMORBIDITE
;
TABAC
;
PSYCHOPATHOLOGIE
;
ALCOOL
;
COCAINE
;
CANNABIS
;
OPIOIDES
;
PREVALENCE
;
FACTEUR DE RISQUE
;
ABSTINENCE
Note générale :
American Journal on Addictions, 2005, 14, (2), 106-123, fig. ; tabl.
Résumé :
This article reviews cigarette smoking in patients with psychiatric disorders (PD) and substance use disorders (SUD). Rates of smoking are approximately 23% in the U.S. population but approximately two- to four-fold higher in patients with PD and SUD. Many remaining smokers have had repeated smoking cessation failures, possibly due to the presence of co-morbid PD and SUDs. There is modest, evidence-based support for effective treatment interventions for nicotine addiction in PD and SUD. Further research is needed to increase our understanding of nicotine addiction in PD and SUD and develop more effective treatment interventions. (Author' s abstract)
Affiliation :
Department of Psychiatry, Yale University School of Medicine, 34 Park Street, New Haven, CT 06519.
Etats-Unis. United States.
Etats-Unis. United States.
Historique